Genelux Stock Quote GNLX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.28

Bid

2.28

Ask

2.30

Volume

34,761

2.27 Day's Range 2.45

1.60 52 Week Range 30.44

Market Cap

78.741M

Previous Close

2.37

Open

2.33

Last Trade

2.29

Last Trade Time

11:06:22

Financial Volume

$ 81,087

VWAP

2.3327

Average Volume (3m)

210,157

Shares Outstanding

34,535,471

Dividend Yield

PE Ratio

-2.82

Earnings Per Share (EPS)

-0.82

Revenue

170k

Net Profit

-28.3M

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vac... Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec, a proprietary, modified strain of the vaccinia virus for the treatment of ovarian cancer and non-small-cell lung cancer. The company is also developing V2ACT Immunotherapy for the treatment of pancreatic cancer; and V-VET1, an animal health product candidate. It has a licensing agreement with ELIAS Animal Health, LLC. Genelux Corporation was incorporated in 2001 and is headquartered in Westlake Village, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.genelux.com

Headquarters

Wilmington, Delaware, USA

Founded

Genelux Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GNLX. The last closing price for Genelux was $2.37. Over the last year, Genelux shares have traded in a share price range of $ 1.60 to $ 30.44.

Genelux currently has 34,535,471 shares outstanding. The market capitalization of Genelux is $81.85 million. Genelux has a price to earnings ratio (PE ratio) of -2.82.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.38	-14.2857142857	2.66	2.83	2.27	144792	2.47715163	CS
4	0.11	5.06912442396	2.17	3.11	1.95	201371	2.45494102	CS
12	0.06	2.7027027027	2.22	3.11	1.6	210157	2.19230565	CS
26	-3.58	-61.0921501706	5.86	6.5	1.6	211869	2.81633852	CS
52	-25.66	-91.8396564066	27.94	30.44	1.6	176468	7.3136082	CS
156	-3.72	-62	6	40.98	1.6	155792	12.0897135	CS
260	-3.72	-62	6	40.98	1.6	155792	12.0897135	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
XPONExpion360 Inc	$ 0.194 (233.33%)	933.75M
BNZIBanzai International Inc	$ 6.60 (129.17%)	45.28M
LFLYLeafly Holdings Inc	$ 2.805 (56.70%)	23.3M
VERBVerb Technology Company Inc	$ 0.0796 (43.17%)	115.96M
GLMDGalmed Pharmaceuticals Ltd	$ 10.36 (23.33%)	12.05M
GSIWGarden Stage Ltd	$ 3.05 (-61.05%)	5.53M
LGCBLinkage Global Inc	$ 0.4028 (-59.26%)	1.3M
CRBPCorbus Pharmaceuticals Holdings Inc	$ 21.68 (-58.07%)	6.97M
SKYESkye Bioscience Inc	$ 2.99 (-45.54%)	1.53M
KOPNKopin Corporation	$ 0.65 (-32.58%)	6.35M
XPONExpion360 Inc	$ 0.1935 (232.47%)	933.08M
VERBVerb Technology Company Inc	$ 0.0796 (43.17%)	115.96M
NVDANVIDIA Corporation	$ 116.25 (-1.37%)	99.64M
HOLOMicroCloud Hologram Inc	$ 0.2486 (7.34%)	58.89M
SVMHSRIVARU Holding Ltd	$ 0.1236 (-0.32%)	58.79M